In early January 2026, Teleflex announced the past departure of Chairman, President and CEO Liam Kelly, appointed long-time ...

Stuart Randle Appointed Interim President and CEOBoard Initiates Search for Permanent CEODr. Stephen Klasko Appointed Chairman of the ...

Fintel reports that on January 27, 2026, Needham upgraded their outlook for Teleflex (NYSE:TFX) from Hold to Buy. Analyst ...

Teleflex shares fell after the medical technology company said it was parting ways with its chief executive officer, and cut its outlook for the year. The stock was down 13% to $110.36 in late morning ...

Teleflex cut its full-year revenue outlook for 2025, citing softer-than-expected demand and order delays. The medical-technologies company on Thursday said it now expects to report revenue of $3.27 ...

What recent performance says about Teleflex Teleflex (TFX) has drawn attention after a mixed stretch, with the stock up about ...

Teleflex Earnings: Inline Earnings, Guidance Improved Due to Less Adverse Tariff Impact Teleflex reported year-on-year quarterly revenue growth of 1% on an adjusted constant currency basis and 9% ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular and peripheral vascular intervention devices WAYNE, Pa., Feb. 27, 2025 ...

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...

The what, where, when, why and how was known, but the who behind a new, roughly 150-employee medical device research facility being built on former VF Outlet Center property in Wyomissing was the big ...